Telephus gets patents for superbug battling antibodies
Australia has granted Telephus Medical a patent for an antibody that targets superbugs, including MRSA.
Australia has granted Telephus Medical a patent for an antibody that targets superbugs, including MRSA.
Athenex will invest a minimum of $1.62 bn over the next ten years in labor, materials, and supplies, to create a new manufacturing facility and to expand its North American headquarters.
Researchers at the Johns Hopkins have developed "mini-brains" made up of human brain cells and neurons which can be reproduced in mass quantities.